Imagine a world where medical imaging struggles to keep up with the needs of an increasingly diverse patient population, leaving clinicians frustrated and diagnoses uncertain in challenging cases. For too long, ultrasound technology has faced significant hurdles when scanning patients with high
What if a remedy hailed as a breakthrough for countless ailments turns out to be more myth than medicine? Across the U.S. and Canada, millions have turned to medical cannabis, hoping for relief from chronic pain, anxiety, and more. Yet, beneath the buzz, a sobering reality emerges: scientific
Imagine a world where life-saving drugs reach patients faster, with fewer animals harmed and costs slashed by millions. This isn’t a distant dream but a tangible goal as the U.S. Food and Drug Administration (FDA) pivots toward human-relevant drug safety models. With new draft guidance released
Could a simple ultrasound, powered by cutting-edge technology, save countless newborn lives by spotting heart defects before birth? At Mount Sinai in New York City, this transformative vision is becoming reality through the integration of artificial intelligence (AI) into prenatal care. This
What if the very speed that delivered lifesaving vaccines also cemented a single-technology playbook that looks nimble in peacetime but brittle under pressure when the next pathogen demands different strengths and a steadier supply chain than speed alone can provide? The COVID-19 race crowned mRNA
Imagine a world where aspiring surgeons can hone their skills without the constant presence of an expert mentor, receiving precise, real-time feedback as they practice critical techniques like suturing. This scenario is no longer a distant dream but a reality being shaped by an innovative AI-driven
Across the human genome, a narrow slice at the very start of genes keeps leaving the same telltale mark—mutations that appear more often than expected and matter more than many once thought, compelling a rethink of how models, pipelines, and clinics treat these small but powerful stretches. Recent
I'm thrilled to be speaking with Ivan Kairatov, a renowned biopharma expert whose extensive experience in research and development has positioned him at the forefront of cutting-edge cancer treatment technologies. Today, we’ll dive into the groundbreaking work on nanodots made from molybdenum
Families and clinicians have long wrestled with the same question: when choices span medication, therapy, and a dozen hopeful alternatives, which option is most likely to help right now without creating new problems later, and how confident should anyone be in that promise. That recurring
Jan Kaiserle sits down with Ivan Kairatov, a biopharma expert deeply versed in molecular therapeutics and translational research, to discuss a new approach to overcoming treatment resistance in neuroblastoma. Drawing on work published in Science Advances in 2025, Kairatov explains how a failed
